Fig Table 1 SCA3 Machado Joseph disease MJD SCA6 SCA31 Dentate rubro pallido luysian atrophy DRPLA SCA2 SCA1 Ataxin 3 Calcium channel
|
|
- みいか こいたばし
- 5 years ago
- Views:
Transcription
1 Review Opinion for Spine Surgeons Key words spinocerebellar degeneration multiple system atrophy progressive supranuclear palsy Parkinson disease spinal cord disease Spinal Surgery Parkinson 1 spinocerebellar degeneration SCD SCD Fig. 1 2 Machado Joseph MJD SCA3 6 spinocerebellar ataxia type 6 SCA6 31 SCA31dentato rubro pallido luysian atrophy DRPLA Table 1 Friedreich 3 2 early onset ataxia with oculomotor apraxia and hypoalbuminemia EAOH AOA1Table 2 cortical cerebellar atrophy CCA multiple system atrophy MSA 3 2 MSA Fig. 1 SCD Address reprint requests to Haruo Shimazaki, M. D., Division of Neurology, Department of Internal Medicine, Jichi Medical University School of Medicine, Yakushiji , Shimotsuke shi, Tochigi , Japan VOL. 26 NO
2 Fig Table 1 SCA3 Machado Joseph disease MJD SCA6 SCA31 Dentate rubro pallido luysian atrophy DRPLA SCA2 SCA1 Ataxin 3 Calcium channel subunit CACNA1A BEAN TK2 Atrophin 1 Ataxin 2 Ataxin 1 W W Table 2 Early onset ataxia with oculomotor apraxia and hypoalbuminemia EAOH AOA1 Autosomal recessive spastic ataxia of Charevoix Saguenay ARSACS Ataxia with oculomotor apraxia type 2 AOA2 SCAR2 Ataxia with isolated vitamin E deficiency AVED Aprataxin Sacsin Senataxin Tocopherol transport protein W W W AFP CK W hereditary spastic paraplegia HSP HSP X W spastic paraplegia 4 SPG4 3 SPG11 Table 3 SCD MRI CCA Fig. 2 a b MJD SCA3 Fig. 2 c d TRH 4 HSP SCD VOL. 26 NO
3 Table 3 SPG4 SPG31 SPG3A SPG11 Spastin Receptor expression enhancing protein 1 REEP1 Atlastin 1 Spatacsin W a b c d Fig. 2 CCA MJD SCA3 MRI CCA MRI T1 a T2 b a b Machado Joseph MJD SCA3 MRI T1 c T2 d c d 2 multiple system atrophy MSA olivopontocerebellar atrophy OPCAShy Drager syndrome SDSstriatonigral degeneration SND OPCA MSA with predominant cerebellar ataxia MSA C SND MSA with predominant parkinsonism MSA P 5 N glial cytoplasmic inclusion GCI neuronal cytoplasmic inclusion NCI 6 Parkinson synucleinopathy SCD SCD MSA C MSA P 7 MSA C MSA C Parkinson MSA P Parkinson L Parkinson Parkinson MSA MRI T2 FLAIR Fig. 3 a Fig. 3 VOL. 26 NO
4 a b c Fig. 3 MSA MRI MSA MRI FLAIR a T2 bmsa MRI T1 c T2 d a c b d d b d Fig. 3 c MSA Parkinson Parkinson 8 MSA 24 SCD progressive supranuclear palsy PSP1964 Steele Richardson Olszewski PSP 10 MRI humming bird sign Fig. 4 aflair Fig. 4 b PSP PSP L 11 PSP parkinsonism PSP P LParkinson 12 PSP C 13 Parkinson ADL VOL. 26 NO
5 a b c Fig. 4 PSP MRI PSP MRI T1 aflair b T1 c PSP humming bird sign a b FLAIR b 4 Parkinson 1 SCD HSP W MRI SCD 2 Parkinson Parkinson MSA P MSA P L Parkinson MSA P MRI Parkinson 123 I MIBG Parkinson MSA Parkinson MSA P 14 PET 11 C BF 227 MSA 15 Parkinson PSP P LParkinson L MRI SCA2 16 SPG11 17 L Parkinsonism 5 Parkinson 1 MRI Tsuji S, Onodera O, Goto J, et al Sporadic ataxias in Japan a population based epidemiological study. Cerebellum , Annual Review Miyai I, Ito M, Hattori N, et al Cerebellar ataxia rehabilitation trial in degenerative cerebellar diseases. Neurorehabil Neural Repair , Gilman S, Low PA, Quinn N, et al Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci , Wakabayashi K, Yoshimoto M, Tsuji S, et al Alpha synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett , Ozawa T, Tada M, Kakita A, et al The phenotype spectrum of Japanese multiple system atrophy. J Neurol Neu- VOL. 26 NO
6 rosurg Psychiatry , Ubhi K, Rockenstein E, Mante M, et al Rifampicin reduces alpha synuclein in a transgenic mouse model of multiple system atrophy. Neuroreport , Steele JC, Richardson JC, Olszewski J Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol , Litvan I, Agid Y, Calne D, et al Clinical research criteria for the diagnosis of progressive supranuclear palsy Steele Richardson Olszewski syndromereport of the NINDS SPSP international workshop. Neurology , º Williams DR, de Silva R, Paviour DC, et al Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy Richardson s syndrome and PSP parkinsonism. Brain , Kanazawa M, Shimohata T, Toyoshima Y, et al Cerebellar involvement in progressive supranuclear palsy A clinicopathological study. Mov Disord , Kikuchi A, Baba T, Hasegawa T, et al Differentiating Parkinson s disease from multiple system atrophy by 123 I meta iodobenzylguanidine myocardial scintigraphy and olfactory test. Parkinsonism Relat Disord , Kikuchi A, Takeda A, Okamura N, et al In vivo visualization of alpha synuclein deposition by carbon 11 labelled 222 dimethylaminothiazol 5 yl ethenyl 62fluoro ethoxy benzoxazole positron emission tomography in multiple system atrophy. Brain , Payami H, Nutt J, Gancher S, et al SCA2 may present as levodopa responsive parkinsonism. Mov Disord , Guidubaldi A, Piano C, Santorelli FM, et al Novel mutations in SPG11 cause hereditary spastic paraplegia associated with early onset levodopa responsive Parkinsonism. Mov Disord , 2011 VOL. 26 NO
Parkinson disease : ,
1 2012 7 24 Parkinson disease :10 50 100, 65 10 200 tremor rigidity (pill rolling) Cogwheel rigidity Akinesia Bradykinesia Resting tremor in Parkinson disease Parkinson disease: camptocormia Parkinson's
More informationMedical Journal of Aizawa Hospital Medical Journal of Aizawa Hospital Vol. 8 (2010) Key words Neuropsychopharmacology Neuroscientist Curr Opin Neurol Clin Rehabil J Neurol Neurosurg Psychiatry
More information56: Hands-on 4 Meet the Expert.
56:136 57 2016 28 5 18 21. 650-0046 6-9-1 650-0046 6-11-1 650-0046 6 10-1 2016 2 9 7 13 Hands-on 4 Meet the Expert. http://www.neurology-jp.org/sokaitiho/neuro2016/ 15,000 18,000 3,000 3,000 3,000 3,000
More informationmedicaljournal8.pdf
Medical Journal of Aizawa Hospital Vol. 8 (2010) Key words Neuropsychopharmacology Neuroscientist Curr Opin Neurol Clin Rehabil J Neurol Neurosurg Psychiatry J Neurol Neurosurg Psychiatry Lancet
More informationet al No To Shinkei Clin Neurol Neurology et al J Neurosurg et al Arch Neurol et al Angiology
37 Recommendations for the Management of Moyamoya Disease A Statement from Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) Research on intractable diseases of the
More informationUnknown
Journal of Breast and Thyroid Sonology Journal of Breast and Thyroid Sonology Vol.2, No.3 July 2013 Report The 30 th Meeting of Japan Association of Breast and Thyroid Sonology... 1 Department of Organ
More informationStabilometry-Significance of Locus Length per Unit Area (L/A) in Patients with Equilibrium Disturbances- Tsuyoshi Okawa, Takashi Tokita, Yasunari Shib
Stabilometry-Significance of Locus Length per Unit Area (L/A) in Patients with Equilibrium Disturbances- Tsuyoshi Okawa, Takashi Tokita, Yasunari Shibata Tetsuya Ogawa, Hideo Miyata 1) Department of Otolaryngology,
More information70% ADCA 28% SCA6 30% MJD 30% DRPLA 13% 20% SCA1 4% SCA2 3% RCA 2% 537 25 T2 C3 C6) LCL MRI OB ph3 ph9 60/40/20mg/ 1000mg/ 3 500mg/ 6 1000mg/ 3 6/ 2 1 2 3 50 25 0 75 100 % 100 33 67 75 80
More information同窓会(本間).indd
76 (4-5): 235 239 (2017) 235 講 演 平成 28 年日本大学医学会秋季学術大会同窓会学術奨励賞受賞講演 -synucleinopathy Ⅰ.α-synucleinopathy? Ⅰ-1.α-synucleinopathy とは -synucleinopathy -synuclein (asyn) 1 Parkinson (Parkinson s disease, PD)
More information118 Dementia Japan Vol. 31 No. 1 January 2017 表 1. DLB に対して mect を行った先行研究 Rasmussen K 2003 USA Japan Japan Japan Japan 1 2
Dementia Japan 31 : 117-124, 2017 117 症例報告 要旨 1. はじめに 70 1 modified electroconvulsive therapy ; mect mect Modified electroconvulsive therapy in dementia with Lewy bodies with drug - resistant psychiatric
More information第4回企画展 わたしたちの脳
"The Wisdom of the Body" The Structure of Brain Peripheral Nervous System Localization of Brain Function Homeostasis The Brain Difference between Humans and Other Mammals The history of brain research
More information第43回岡山脳研究セミナー抄録集ハンドアウト原稿Final
第 43 回岡山脳研究セミナーのご案内テーマ : 睡眠覚醒の脳科学と疾患 9:05 10:05 一般口演 スケジュール 日時 : 平成 29 年 1 月 29 日会場 : 医学部臨床第二講義室参加費 : 無料 10:15 12:15 特別講演 全身 全脳透明化の先に見えてくるもの ~ 生命の 時間 の謎の解明に向けて ~ 上田泰己先生 ( 東京大学大学院医学系研究科システムズ薬理学 / 理化学研究所
More informationUnknown
Journal of Breast and Thyroid Sonology Journal of Breast and Thyroid Sonology Vol.3, No.3 July 2014 Original Article Clinical significance of classification of mixed-pattern tumor by breast ultrasound...
More informationMicrosoft PowerPoint UTNP.ppt
Neuropathology Shigeo Murayama 2007.05.21 Department of Neuropathology (Brain Bank) Tokyo Metropolitan Institute of Gerontology Today s Themes A. General consideration Hierarchy of the nervous system Dynamic
More information..
A general framework of interventional study in cognitive rehabilitation for the elderly. YOSHIDA Hajime, OOKAWA Ichiro and TUCHIDA Noriaki The present article describes the general framework of our interventional
More informationDiagnosis of Dementia: Update
10 C A 1 2 Normal SMI MCI Early Dementia B Moderate Dementia 3 Severe Dementia 4 5 D AD, VD, FTD, DLB, PDD Depression Dementia d/t GMC Modifiable risk factors and preventive factors for dementia 6-5 -
More informationGraduate School of Clinical Psychology, Kibi International University 8 Iga-machi, Takahashi, Okayama, Japan(716-8508) Research Institute of Clinical Psychology, Kibi International University Department
More information104 岩波正興 DJMS 対象症例 PD:Parkinson disease, MSA:multiple system atrophy, PSP:progressive supranuclear palsy, PSP-RS:Richardson s syndrome, PSP-P:PSPparki
Dokkyo Journal of Medical Sciences (:103 109,2011 103 パーキンソン関連疾患における経頭蓋超音波検査による 中脳黒質の高輝度変化の検討 獨協医科大学内科学 ( 神経 ) 2) 獨協医科大学病院超音波センター 岩波正興 宮本智之 宮本 雅之 髙田 2) 悦雄 平田 幸一 : パーキンソン病 (Parkinson disease:pd), 多系統萎縮症
More informationプログラム_指定演題.indd
400 Dementia Japan Vol. 27 No. 4 October 2013 11 9 13 45 14 15 1 : 11 9 14 15 15 15 1 : β β Jorge A Ghiso Departments of Pathology and Psychiatry, New York University School of Medicine, New York, USA
More information56: 巻 7 号 (2016:7) パートの 意 見 から 作 成 された red flag check list から,MSA と Parkinson disease(pd)の 鑑 別 に 有 用 な 項 目 として 抽 出 された ものである 7). 第 2 回 コンセンサス 会
56:457 1 2 2 2 2 2 1 3 4 2 1 5 * 多 系 統 萎 縮 症, 早 期 診 断, 突 然 死, 自 律 神 経 不 全, 認 知 症 多 系 統 萎 縮 症 (multiple system atrophy; MSA)は, 独 立 した 疾 患 として 見 出 されたオリーブ 橋 小 脳 萎 縮 症 (olivopontocerebellar atrophy; OPCA),
More information日本職業・災害医学会会誌第51巻第5号
太田ら 同時多発性高血圧性脳葉出血の 1 手術例 図 1 搬入時 CT 上段 単純 CT 下段 造影 CT 図 2 術後の脳血管撮影検査では明らかな出血源は認めない 379 Reprint request: MULTIPLE SIMULTANEOUS HYPERTENSIVE LOBAR HEMORRHAGE Hirotsugu OHTA M.D. 1) and Akira YOKOTA M.D.
More informationJournal of Breast and Thyroid Sonology Journal of Breast and Thyroid Sonology Vol.2, No.1 January 2013 Overview History of JABTSJapan Association of Breast and Thyroid Sonology : Dawn of a JABTS Age; The
More informationuntitled
239 10 3 14 00 14 50 1 : 10 2 10 30 11 30 1 : 10 4 13 00 14 00 1 : 10 2 13 00 14 00 1 : Peter St. George - Hyslop University of Toronto 10 2 14 10 15 10 1 : Randall Bateman Neurology at Washington University
More information23 7 24 3 49 237 24 3 (1) 23 7 7 (2) 4 23 1) European Fedaration of Neurological Societies, Sep 10-13, 2011Budapest, Hungary the 1 st Korea-Japan NeuroRehabilitation Coference, March 17, 2012, Seoul, Korea
More informationJ Life Sci Res 2014; 12: Osaka Prefecture University Journal of Life Science Research Online ISSN
J Life Sci Res 2014; 12: 15-19 2014 Osaka Prefecture University Journal of Life Science Research Online ISSN 2186-5809 583-8555 3-7-30 577-8567 3-1-1 2014 9 11 2014 10 21 Exposure mild-level LED light
More information3号表し
Jichi Medical School Annual Report of Nursing 13 13 a 15 16 18 18 19 20 21 25 25 27 29 31 34 36 37 39 45 45 46 46 47 49 50 50 51 200416 55 55 56 2002 740 880 16201997 12 21 3 15 1516 1 10 3 513 1235000
More informationClinical Study of Effect of Intrathecal Use of Alpha-tocopherol on Chronic Vasospasm Hirotoshi Sano, Motoi Shoda, Youko Kato, Kazuhiro Katada, Youichi
Clinical Study of Effect of Intrathecal Use of Alpha-tocopherol on Chronic Vasospasm Hirotoshi Sano, Motoi Shoda, Youko Kato, Kazuhiro Katada, Youichi Shinomiya and Tetsuo Kanno Department of Neurosurgery,
More information1. Paul, L. W. and Juhl, H.: The Essentials of Roentgen Interpretation. Harper & Row, Publishers. pp. 339-355, 1972. 2. Norman, D., Diamond, C. and Boyd, D.: Relative detectability of intracranial calcifications
More informationβ β β β β β
β β β β β β β β β β β β β β β β β θ β α γ et al et al et al β β et al β et al in vivo et al γ et al et al et al et al et al et al Ectopic fat deposition, type 2 diabetes mellitus and cardiovascular diseases
More information第124回日本医学会シンポジウム
III γ γ γ α γ Molecular Mechanism of Insulin Resistance by Adipocytes TAKASHI KADOWAKI Department of Metabolic Diseases, Graduate School of Medicine, University of Tokyo Key words γ 110 124 TNFα FFA 1,2
More informationTable 1.Concentration of gatifloxacin (Middle-ear) Table 2.Concentration of gatifloxacin (Paranasal sinuses) Table 3.Concentration of gatifloxacin (Tonsil) Table 4.No.of patients studied Table 5.Background
More information56: 巻 3 号 (2016:3) 1968 年,Rebeiz らは, 進行性の左右非対称な筋強剛と失行に加え, 皮質性感覚障害,alien limb sign, ミオクローヌス, ジストニアを認める 3 症例を報告した 1). 病理学的には大脳皮質, 黒質, 小脳歯状核の変性と, 胞
56:149 1 * 2 1 大脳皮質基底核症候群, 大脳皮質基底核変性症, 診断基準,Armstrong 基準, タウオパチー 大脳皮質基底核変性症 (corticobasal degeneration; CBD) は, 大脳皮質と皮質下神経核 ( とくに黒質と淡蒼球 ) の神経細胞 が脱落し, 神経細胞およびグリア細胞に異常リン酸化タウが 蓄積する 4 リピート タウオパチーである. 近年,CBD
More informationVol.0 No. 0 図 Montreal Cognitive AssessmentMoCA orientation visuospatial attention orientation 4 visuospatial executive MMSE MoCA language language me
Parkinson 病の認知機能障害を MMSE と MoCA により評価した多施設共同研究 : 慶應 PD データベース Cognitive impairment in Parkinson s disease patients evaluated by the Montreal Cognitive Assessment and the Mini-Mental State Examination.
More information1) Waardenburg PJ : A new syndrome combining developmental anomalies of the eyelids, eyebrows and nose root with pigmentary defects of the iris and head hair and with congenital deafness. Am J Hum Genet
More information神経変性疾患
神 経 変 性 疾 患 神 経 変 性 疾 患 とは 特 別 な 誘 因 が 無 く,ある 特 定 の 神 経 細 胞 群 が 徐 々にゆっく り 変 性 していく 疾 患 の 総 称 神 経 変 性 疾 患 の 特 徴 1. 原 因 不 明 2. 徐 々に 発 症 3. 緩 徐 に 進 行 4. 症 状 は 対 称 性 5. ある 種 の 系 統 が 障 害 6. 家 族 性 のことがある 変 性
More information第58巻6号/投稿規定・目次・表2・奥付・背
Feature articles 1Why is it that allergic diseases have been increasing? Feature articles 2Space medicine and medicine for the future Review γ ε γ γ γγ α αβ et al et al et al et al et al et al Is nutritional
More information3) Stedmann, E. et al.: Biochem. J., 29; 2107, 1935. 4) Reiss, M.. Hemphill, R. E. E ENature, 161 ; 18, 1948. 5) Tower, D. B. & D. MeEachern: Canada J. Reserch., 27; 105, 120, 132, 1949. 6) Wolleman, M.
More information) 5 Lawton QOL 4 4 QOL Lawton 4) Philadelphia Geriatric Center Affect Rating ScaleARS ARS QOL 5) HDS R
Vol. 12 No. 2 2002 389 397 Λ1 Λ2 16 10 30 1 2 Lawton Philadelphia Geriatric Center Affect Rating ScaleARS Lawton ARS + ARS 6 2 ARS 2 12:00 15:0017:00 11:30 16:00 1 2 ARS 1 2 ARS QOL QOL QOL 1) QOL QOL
More information第57巻6号/投稿規定・目次・表2・奥付・背
γ Present status of anti-hiv therapy Akio Adachi Department of Virology, The University of Tokushima School of Medicine, Tokushima, Japan Epidemiological survey of sexually transmitted disease
More information± ± ± ± ± D - CTA 1 1 Mini - mental state examination MMSE Raven s
164 Dementia Japan 25 : 164-169, 2011 Mini - mental state examination 36 30 83.3% Raven s colored progressive matrices 31 20 64.5% Frontal assessment battery 34 26 76.5% Shinichiro Maeshima 1, Aiko Osawa
More information本文/依頼2_和気先生(4C) ☆
Ann Jpn Prosthodont Soc 4 : 256-266, 2012 Historical Changes of Psychosomatic Therapy for Patients with Temporomandibular Disorders Hiroyuki Wake, PhD, DDS a, and Osamu Komiyama, PhD, DDS b 256 257 258
More information平成14年度 本態性多種化学物質過敏状態の調査研究 研究報告書
226 227 µ 228 Ω 229 230 0 ppb 2000ppb DG subthreshold (µa) 91 ± 59 86 ± 68 max stim. (µa) 755 ± 287 n=37 678 ± 300 max PS (mv) 8.7 ± 3.9 7.7 ± 4.3 n=61 CA1 subthreshold (µa) 36 ± 26 32 ± 13 max stim. (µa)
More information日本消化器外科学会雑誌第29巻第9号
Table 1 Oligonucleotide primers used for RT-PCR and internal probes used for Southern blot hybridization Cytokine Primer Sequence (5'-3') 5' 3' Internal probe s' 3' Internal probe 5' 3' Internal probe
More information第56巻6号/投稿規定・目次・表2・奥付・背
Feature articlesthe Front of Stroke Management Originals α Imaging protocol for apoplexy of acute phase Masafumi Harada, Kazuhide Yoneda, Naomi Morita, Mayumi Takeuchi, Sonoka Hisaoka, Toshiko Okada,
More informationジャーナル4表紙
Jichi Medical University Journal of Nursing 7 3 4 55 63 75 a 83 93 97 3 9 5 9 3 5 7 97 5 9 6 ) 5) ) 36) 35 336 3 4 9 34 56 78 9 36 7 67 3 3 4 3 97 3 5 5 7 5 3 3 4 5 97 5 9 979 7 8564 887 97948 4 4 6
More informationエンジョイ北スポーツ
2772083130 83 1 2 3 4 5 6 7 8 2 2 2 3 3 4 4 6 7 8 1211 53 /15,171 /509 /670 /13,992 2 83130 http://www.kita-city-taikyo.or.jp 83130 http://www.kita-city-taikyo.or.jp 3 68 35 45 4 83130 http://www.kita-city-taikyo.or.jp
More information第61巻5・6号(12月号)/特集1頁目(本刷)
Special Issue 1Sudden cardiac death symposium in Tokushima Special Issue 2How to do for your health? Reviews Original Epidemiologic problems of sudden death of school children in Tokushima Prefecture
More informationFig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly notified cases of all fo
Kekkaku Vol. 79, No. 1: 17-24, 2004 17 (Received 21 Aug. 2003/Accepted 18 Nov. 2003) Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly
More informationSpecial IssueDiagnoses and therapeutic agents for age-related diseases Reviews Original Case reports β Medicinal drugs affecting on clinical laboratory blood test results and adverse effects of them
More informationW baclofen dystonia 1 Parkinson 10 5% botulinum toxin ; BTX deep brain stimulation ; DBS BTX DBS BTX DBS Oppenheim 1911 dystonia m
2011 43 183 188 183 W baclofen dystonia 1 Parkinson 10 5% botulinum toxin ; BTX deep brain stimulation ; DBS BTX DBS BTX DBS Oppenheim 1911 dystonia musculorum deformans DMD DYT1 1980 1800 Bell Duchenne
More information★索引.indb
S 703 S 704 S 705 S 706 S 707 S 708 S 709 S 710 S 711 S 712 S 713 S 714 S 715 S 716 S 717 S 718 20 4 15 Japanese Journal of Medical Ultrasonics 35 101 0063 2 23 1 6 F The Japan Society of Ultrasonics in
More information第59巻4,5号(10月号)/投稿規定・目次・表2・奥付・背
Special IssuePhysiology, psychology and treatment of eating disorders Reviews Originals Proceeding Case Report ob α α et al. et al et al Control of food intake Kyoichi Kishi, Kazuhito Rokutan, Takeshi
More informationuntitled
5 K 5 3 HP http://www.mhlw.go.jp/bunya/shakaihosho/iryouseido01/taikou03.html 2004 1 2 1 http://www.dm-net.co.jp/calendar/2007/06/005835.php 6 85cm 100cm 2 90cm 2 TG 150mg/dl HDLHDL-C 40mg/dl 130mmHg 85mmHg
More information老年医学update2007-08
Geriatric Medicine Update 2007-08 (ISBN978-4-7583-0298-2 C3002) Editor: Journal Publication Committee, The Japan Geriatrics Society 2007. 7. 1 1st ed MEDICAL VIEW, 2007 Printed and Bound in Japan Medical
More information立命館21_松本先生.indd
2143-552010 1 2 () 1 2 3 456 78- Key Words 1 3 12007 2 3 508 19992008 1 23 4 43 2120107 4 2008 1992 2003 2005 1989 2008 4 2 2-1 10 4 4 6 5 4 5 2946 1 155 11 41 44 45 4 2-2 2003 1 21 2 1 3 4 5 6 7 3 2120107
More information立命館20_服部先生.indd
20 93-105 2010 2 () ' - 1 ( ) ( ' 2005) Key Words 2 1967 93 20 2010 1 94 1 ' 2002 2 2 1996 1996 1999 2 2 2 1993 1999 4 1 2 1985 1989 1986 1994 4 1 2 1 1 4 2 4 4 1 4 1966 4 10-1970 20 1993-1972 95 20 2010
More information1996 2000 2004 1984 2005 7150 000 9 500 9 4 13 10 95 11 11 12 20002004 9 70
14 2006 1 Key Words 2002 3 1 2 3 3 1 2 3 1969 1987 69 1996 2000 2004 1984 2005 7150 000 9 500 9 4 13 10 95 11 11 12 20002004 9 70 14 2006 1 15 71 72 1 22 6 32 9 200 6 3 1 2 2000 10 1 2003 10 2005 6 5 4
More information立命館16_坂下.indd
1669-792008 1 - ' 85- -108 ' Key words 1 2 2003 69 1620082 5 3 1990 1997 4 5 2001 1307 6 7 1 1 1 1996 100 2 1997 71 3 1998 71 4 1999 96 5 2000 95 6 2001 145 7 2002 191 8 2003 174 9 2004 120 10 2005 122
More information立命館人間科学研究No.10
1 77 5 Key words 1 23 3 11417 14310045 20022004 2 2003 20022005 20022004 2 10200511 3 2003 1152003 59 1995 3 32003 19932002 20032003 2005 20052005 4 1997 2000521986 2001 42001 3 1981 6 1 7 5 1000248 1632647
More information立命館21_川端先生.indd
21 119-132 2010 ( ) ' Key Words 119 21 2010 7 1962 2001 2001 2007 1982 1988 1997 2007 1997 1998 1863 1880 1 1998 1998 2001 1599 120 121 1599 1695 8 1695 1714 4 1714 1715 5 1715 100 1812 9 1812 1864 2001
More information立命館14_前田.indd
1499-1122007 1 ) ) ) ) ) (1) -- ) ) ) ) ) ) ( ) ) ' ) ) ) ) - 1) 2)' 3) Key words 19811994 1721 99 1420073 100 20012004 2005 2004 2002 33 34 10 1987 45 20002003 2002 1 1 2000 1 1 2001 2 200341 12004 2
More information立命館17_坂下.indd
1793-1052008 1 () -- -- - Key words 1 93 1720088 2 3 2003 15 1996 50 3040 2 3 4050 50 10 1980 1995 1950 1958 1968 1972 94 95 1987 4 4 70 3 3 1 2000 2001 4 1720088 96 2001 2003 2 1978 1990 1997 130 2 3
More information立命館人間科学研究No.10
49 00 7 Key words 980 995 50 0005 90 997 99 990 994 99 99 99990 99 996 988988 994 99 995 995 995 994 984 988 986 997 997 00 995 00 5 7 5 5 999 997 997 998 6 998 999 997 997 998 0040000 994 996 000 00 5
More information立命館19_椎原他.indd
191-132009 1 ( ) ' Key Words 1 11 12007 2007 200520062 201120062 7558 4009 1 1920098 2007 2 2000 028 2005 1999 12 1999 13 1968 2 3 '1992 2007 2001 20052001 1977 2005 2005 2007 21 21 22 461927 3 13 1920098
More information立命館人間科学研究No.10
61 10 1990 Key words 1 102005 11 62 2000 1 1920 10 1892 63 1 1 19 100 1914 100 1 1 20 1 2 102005 11 64 1946 21 4 1947 1949 1947 22 1 3 1956 1959 1958 2 1964 65 2 10 1975 7080 70 2 1 1987 1990 40 1989 1989
More information立命館19_徳田.indd
1991-1022009 1 2 () )--) 28 2827 1 2 Key Words 1 (1721 2000 20012001 20082009 91 1920098 92 20042004 2004 2001 12 2005 20082009 2005 3 1997 200820096 2007 2 20082009 93 20012001 12 2008 2009 19611966 1
More informationPD_PET_Resume
PET パーキンソン病とは パーキンソン病は 脳の中の黒質 図1 という部分 の神経細胞が変化してしまう病気です 黒質からは線条 目 体 尾状核 被殻などで構成 という部分に軸索という 枝が出ていて ドパミンという神経の信号を伝えるため 鼻 の物質をシナプスと呼ばれる場所で出しています 図 2 パーキンソン病では このドパミンが減ってしまい 口 ます 20%以上低下すると症状が出ると言われていま す
More informationNIHSS score p NIHSS score p149 4 p g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml
NIHSS score14 1 400 1 p149 1 25 20 NIHSS score14 15 10 5 2 p149 4 p151 0 0.8 g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml 1 2 148 149 3 2 3 A B C 4 D 2 A B C A C 1 Ogata T et al J Neurol Sci 272 83 86 2008
More informationuntitled
1 2 21-3 CS VOC- CS syasuma@tc4.so-net.ne.jp 4 [] MCS, 200501212B () SHSMCS CS 66 14 16 5 () MCS 16 (GSTs) 14 (8ppb40ppb) 2002192155-161) 6769 68 68 EPA Terr, 1989 69 QEESI 3 70 6 EPA MCS 10 9 8 MCS 6
More information好酸球性副鼻腔炎:診断ガイドライン(JESREC Study)
118 728 2015 : : JESREC Study Japanese Epidemiological Survey of Refractory Eosinophilic Chronic Rhinosinusitis Study : JESREC Study CT NSAIDs CT : JESREC Study JESREC Study 118 729 ph CTMRI Caldwell Luc
More informationflF™m…−…n„Efic’æ’¶
44 2006 Cognitive Rehabilitation by means of Personal Computer for Cerebrovascular Disease Patients with Attentional Disorders 1 1 2 2 5 4 1 PC ABA design 4 PASATTMT Ponsford PC SAS working memoryattention
More information55: 巻 4 号 (2015:4) Brain MRI. MRI of the patient (A, B), his mother (C, D) and uncle with PSP (E). revealed atrophy (arrows) of the upper vermis
55:243 spinocerebellar ataxia type 6 SCA6 1 1 1 4 2 3 3 1 * spinocerebellar ataxia type 6(SCA6), パーキンソン症状, レボドパ反応性,DAT スキャン, 黒質線条体 脊髄小脳変性症 6 型 (spinocerebellar ataxia type 6; SCA6) は, 第 19 染色体短腕に存在する P/Q
More information1991 1991 FAX e-mail 1999.12. 1 1999.12. 31 042-783-2305 4342 194-0298 F 042-783-2311 79 98.11 A4.39 97.11 21 A5.90 97. A5.286 98. 21 A5.197 99.10 A5.276 99.10 B5.22 99.10 B5.24 99. B40.170 99. A5.174
More information<93C195CA D834F E696E6464>
45 I I Diabetes and Heart: Insight by Imaging Juhani Knuuti Turku PET Centre, Turku University Central Hospital II I Development and Application of Beta-Amyloid Imaging Agents Chet A. Mathis Department
More information耳鼻咽喉科の診療に関連した味覚障害
25 1 17 22, 2012 QOL Canal wall up Bell 17 25 1 (%) 100 ** P0.008 80 60 40 20 No recovery Complete recovery 0 2W 6M 0-20 years n=18 2W 6M 2W 6M 21-40 years n=15 41-60 years n=27 3 2 1 Noninfla COMChole
More information顔面神経麻痺を来したMPO―ANCA 陽性の中耳炎2症例
11367 : MPOANCA MPO ANCA MPOANCA 134EU MPO ANCA 67EU MPOANCA ANCA : MPOANCAANCA antineutrophil cytoplasmic antibody ; ANCA Davies IgG ANCA PR3proteinase3ANCA MPOmyeloperoxidaseANCA Wegener PR3ANCA MPO
More informationuntitled
8 2012211 2012 8 2012211 TEL048-758-1811FAX048-758-1818 E-mailhagiwara.shinichiro@pref.saitama.lg.jp 8 7 5 101 0003 2 6 2 03 3230 2831 7F 703 704 707 705 8 1000 1005 1 1010 1050 O-01 Yersinia pseudotuberculosis
More informationFig. 2 Signal plane divided into cell of DWT Fig. 1 Schematic diagram for the monitoring system
Study of Health Monitoring of Vehicle Structure by Using Feature Extraction based on Discrete Wavelet Transform Akihisa TABATA *4, Yoshio AOKI, Kazutaka ANDO and Masataka KATO Department of Precision Machinery
More information21-07_後藤論文.smd
2015; 21: 5866 Yoichi Goto: Current status and future perspective of cardiac rehabilitation in Japan. J Jpn Coron Assoc 2015; 21: 5866 I 1 1 3 1 2 3 QOL 2 Fig. 1 1 196070 AMI AMI 1980 AMI CABG comprehensive
More information